ES2181017T3 - Composicion farmaceutica que contiene una sustancia promotora de osteogenesis y un polietilenglicol. - Google Patents
Composicion farmaceutica que contiene una sustancia promotora de osteogenesis y un polietilenglicol.Info
- Publication number
- ES2181017T3 ES2181017T3 ES97935871T ES97935871T ES2181017T3 ES 2181017 T3 ES2181017 T3 ES 2181017T3 ES 97935871 T ES97935871 T ES 97935871T ES 97935871 T ES97935871 T ES 97935871T ES 2181017 T3 ES2181017 T3 ES 2181017T3
- Authority
- ES
- Spain
- Prior art keywords
- pharmaceutical composition
- polyethylene glycol
- osteogenesis
- promoting substance
- composition containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
LA INVENCION SUMINISTRA UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UNA SUBSTANCIA NO PEPTIDICA PROMOTORA DE LA OSTEOGENESIS Y UN GLICOL DE POLIETILENO O UN DERIVADO DEL MISMO, QUE PUEDE UTILIZARSE DE FORMA VENTAJOSA COMO AGENTE PARA LA PREVENCION O EL TRATAMIENTO DE DIFERENTES ENFERMEDADES DE LOS HUESOS (POR EJ. LA OSTEOPOROSIS) EN VISTA DE LA ALTA CAPACIDAD DE ABSORCION ORAL Y DE LA GRAN ESTABILIDAD DEL INGREDIENTE ACTIVO.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22344396 | 1996-08-26 | ||
JP9040897 | 1997-04-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2181017T3 true ES2181017T3 (es) | 2003-02-16 |
Family
ID=26431895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97935871T Expired - Lifetime ES2181017T3 (es) | 1996-08-26 | 1997-08-25 | Composicion farmaceutica que contiene una sustancia promotora de osteogenesis y un polietilenglicol. |
Country Status (9)
Country | Link |
---|---|
US (1) | US6190695B1 (es) |
EP (1) | EP0949927B1 (es) |
AT (1) | ATE226078T1 (es) |
AU (1) | AU3868997A (es) |
CA (1) | CA2264131A1 (es) |
DE (1) | DE69716469T2 (es) |
ES (1) | ES2181017T3 (es) |
ID (1) | ID18079A (es) |
WO (1) | WO1998008517A2 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IS4518A (is) * | 1997-07-09 | 1999-01-10 | Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group | Nýtt lyfjaform fyrir bóluefni |
AU4165699A (en) * | 1998-06-15 | 2000-01-05 | Takeda Chemical Industries Ltd. | Composition for treating cartilage disease |
WO2000008018A1 (fr) | 1998-08-07 | 2000-02-17 | Takeda Chemical Industries, Ltd. | Derives de benzothiepine, leur procede de preparation et leurs utilisations |
CA2340165A1 (en) * | 1998-08-12 | 2000-02-24 | Haruhiko Makino | Enhancer of cell differentiation induction factor |
CA2378486A1 (en) * | 1999-08-05 | 2001-02-15 | Takashi Kurasawa | Osteogenesis promoter sustained-release paste |
EP1293197A1 (en) * | 2000-06-23 | 2003-03-19 | Takeda Chemical Industries, Ltd. | Process for producing phospholipid-containing drugs |
JP4176475B2 (ja) * | 2001-01-19 | 2008-11-05 | 博徳 山本 | 内視鏡用注射剤 |
US6855332B2 (en) * | 2002-07-03 | 2005-02-15 | Lyfjathroun Hf. | Absorption promoting agent |
US8158685B2 (en) * | 2004-07-02 | 2012-04-17 | Gregory Gene Steiner | Method for bone growth |
ES2593047T3 (es) | 2006-02-03 | 2016-12-05 | Opko Renal, Llc | Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3 |
ES2670029T3 (es) | 2006-06-21 | 2018-05-29 | Opko Ireland Global Holdings, Ltd. | Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D |
DK2148684T3 (da) * | 2007-04-25 | 2013-04-22 | Cytochroma Inc | Fremgangsmåde til behandling af vitamin D-insufficiens og -deficiens |
US20100144684A1 (en) | 2007-04-25 | 2010-06-10 | Proventiv Therapeutics, Inc. | Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease |
EP2148685A4 (en) * | 2007-04-25 | 2010-07-28 | Cytochroma Inc | METHODS AND COMPOUNDS FOR THERAPY BASED ON VITAMIN D |
EP2762132A1 (en) * | 2007-04-25 | 2014-08-06 | Cytochroma Inc. | Controlled Release 25-Hydroxyvitamin D |
CN106853250A (zh) | 2008-04-02 | 2017-06-16 | 赛特克罗公司 | 用于维生素d缺乏症和相关障碍的方法、组合物、用途和试剂盒 |
PT2552484T (pt) | 2010-03-29 | 2020-04-03 | Opko Ireland Global Holdings Ltd | Métodos e composições para redução dos níveis de parafróides |
KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 d 방출 제형 |
SG10201911274TA (en) | 2014-08-07 | 2020-02-27 | Opko Ireland Global Holdings Ltd | Adjunctive therapy with 25-hydroxyvitamin d |
TWI747893B (zh) | 2016-03-28 | 2021-12-01 | 愛爾蘭商歐科愛爾蘭全球控股股份有限公司 | 維生素d治療之方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4906475A (en) * | 1988-02-16 | 1990-03-06 | Paco Pharmaceutical Services | Estradiol transdermal delivery system |
NZ231939A (en) | 1988-12-28 | 1991-07-26 | Takeda Chemical Industries Ltd | Benzothiopyran derivatives and medicaments |
ATE203020T1 (de) * | 1990-05-30 | 2001-07-15 | Takeda Chemical Industries Ltd | Schwefel enthaltende heterocyclische verbindungen |
AU6586394A (en) * | 1993-04-22 | 1994-11-08 | Celtrix Pharmaceuticals, Inc. | Conjugates of growth factor and bone resorption inhibitor |
JP3319625B2 (ja) * | 1993-05-12 | 2002-09-03 | ホーユー株式会社 | 速崩壊性生薬製剤 |
TW403757B (en) * | 1994-12-28 | 2000-09-01 | Takeda Chemical Industries Ltd | Optically active benzothiepin derivative, its preparation and use |
RU2188011C2 (ru) * | 1995-06-05 | 2002-08-27 | Такеда Кемикал Индастриз, Лтд. | Активирующая остеогенез фармацевтическая композиция |
-
1997
- 1997-08-25 CA CA002264131A patent/CA2264131A1/en not_active Abandoned
- 1997-08-25 WO PCT/JP1997/002941 patent/WO1998008517A2/en active IP Right Grant
- 1997-08-25 EP EP97935871A patent/EP0949927B1/en not_active Expired - Lifetime
- 1997-08-25 AU AU38689/97A patent/AU3868997A/en not_active Abandoned
- 1997-08-25 ID IDP972959A patent/ID18079A/id unknown
- 1997-08-25 DE DE69716469T patent/DE69716469T2/de not_active Expired - Lifetime
- 1997-08-25 AT AT97935871T patent/ATE226078T1/de not_active IP Right Cessation
- 1997-08-25 ES ES97935871T patent/ES2181017T3/es not_active Expired - Lifetime
-
1999
- 1999-02-09 US US09/246,851 patent/US6190695B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69716469T2 (de) | 2003-02-20 |
EP0949927A2 (en) | 1999-10-20 |
EP0949927B1 (en) | 2002-10-16 |
WO1998008517A3 (en) | 1998-05-07 |
ID18079A (id) | 1998-02-26 |
DE69716469D1 (de) | 2002-11-21 |
US6190695B1 (en) | 2001-02-20 |
WO1998008517A2 (en) | 1998-03-05 |
ATE226078T1 (de) | 2002-11-15 |
CA2264131A1 (en) | 1998-03-05 |
AU3868997A (en) | 1998-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2181017T3 (es) | Composicion farmaceutica que contiene una sustancia promotora de osteogenesis y un polietilenglicol. | |
AR015946A1 (es) | Formulacion farmaceutica que comprende bifosfonatos, proceso para su preparacion, uso de la formulacion para la fabricacion de un medicamento, metodo parala inhibicion de la reabsorcion osea, y metodo para el tratamiento y prevencion de osteoporosis | |
AR020055A1 (es) | Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma. | |
GT199700009AA (es) | Terapia combinada para la osteoporosis | |
DE69910230D1 (de) | Paclitaxel enthaltende arzneimittel | |
BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
SE9901272D0 (sv) | New improved formulation | |
ATE447947T1 (de) | Pharmazeutische zubereitungen zur behandlung von insulinresitenz | |
HUP0001170A3 (en) | Pharmaceutical compositions containing benzimidazole-2-carbamate derivatives as active ingredients for the treatment of viral infections and cancer | |
DE69530926D1 (de) | Mittel zur förderung des haarwachstums | |
DK0679393T3 (da) | Pharmaceutisk præparat til behandling af osteoporose indeholdende xanthohumol | |
ATE395071T1 (de) | Pharmazeutische zubereitungen zur angiogenese- therapie | |
AP1424A (en) | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens. | |
BR0008509A (pt) | Composição farmacêutica oral estabilizada contendo iodeto e iodato e método | |
ATE260650T1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
DE69907926D1 (de) | 1,2,4-triazol-3-thion verbindungen | |
YU16399A (sh) | ) UPOTREBA INHIBITOR H +, K+ - ATP- aze I FARMACEUTSKA FORMULACIJA ZA SIMULTANU, SEPARATNU ILI SEKVENCIJALNU UPOTREBU, KOJA SADRZI INHIBITOR H +, K+-ATP- aze I GLUKOKORTIKOID INHIBITOR H +, K+- ATP- aze | |
ATE464878T1 (de) | Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl | |
PT1150681E (pt) | Utilizacao de uma composicao farmaceutica que contem desoxipeganina para o tratamento da dependencia da nicotina | |
ES2041243T3 (es) | Aplicacion de por lo menos un principio activo inhibidor o destructor de por lo menos un ser vivo unicelular o virus. | |
DE69817379D1 (de) | Pharmazeutische zubereitungen enthaltend ibuprofen und domperidon zur behandlung von migräne | |
AR003001A1 (es) | Composicion farmaceutica estimuladora de la osteogenesis. | |
HRP20000781B1 (en) | Effervescent preparations | |
EP1084710A4 (en) | DRUGS AGAINST MALE STERILITY | |
ATE208402T1 (de) | Pharmazeutische zusammensetzung enthaltend interferon-gamma inhibitoren |